BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Feb 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-21

Reporting Person: Nanavaty Maulik (SVP & Pres, Neuromodulation)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-21	Common Stock	M	1713.0000	$0.0000	Acquired	264884.0000	Direct
2020-02-21	Common Stock	F	850.0000	$42.6200	Disposed	264034.0000	Direct
2020-02-22	Common Stock	M	1883.0000	$0.0000	Acquired	265917.0000	Direct
2020-02-22	Common Stock	F	934.0000	$42.6200	Disposed	264983.0000	Direct
2020-02-23	Common Stock	M	1840.0000	$0.0000	Acquired	266823.0000	Direct
2020-02-23	Common Stock	F	913.0000	$42.6200	Disposed	265910.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Deferred Stock Units	$	M	1713.0000	Disposed	2023-02-21	Common Stock (1713.0000)	Direct
2020-02-22	Deferred Stock Units	$	M	1883.0000	Disposed	2021-02-22	Common Stock (1883.0000)	Direct
2020-02-23	Deferred Stock Units	$	M	1840.0000	Disposed	2020-02-23	Common Stock (1840.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.